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Abstract
Background: A hot new topic in medical treatment is the use of mesenchymal stem cells (MSC)
in therapy. The low frequency of this subpopulation of stem cells in bone marrow (BM) necessitates
their in vitro expansion prior to clinical use. We evaluated the effect of long term culture on the
senescence of these cells.
Results: The mean long term culture was 118 days and the mean passage number was 9. The
average number of PD decreased from 7.7 to 1.2 in the 10th passage. The mean telomere length
decreased from 9.19 Kbp to 8.7 kbp in the 9th passage. Differentiation potential dropped from the
6th passage on. The culture's morphological abnormalities were typical of the Hayflick model of
cellular aging.
Conclusion: We believe that MSC enter senescence almost undetectably from the moment of in
vitro culturing. Simultaneously these cells are losing their stem cell characteristics. Therefore, it is
much better to consider them for cell and gene therapy early on.
Background
Mesenchymal stem cells (MSC) are of great therapeutic
potential because of their ability to self-renew and differ-
entiate into multiple tissues[1]. They enhance engraft-
ment of donor hematopoietic cells after co-
transplantation in animal models[2]. In humans, MSC
have been used to regenerate the marrow microenviron-
ment after myeloablative therapy[3]. Possible clinical
applications proposed for MSC include: stem cell trans-
plantation[4], stem cell strategies for the repair of dam-
aged organs[5] and gene therapy[6]. Friedenstein first
described[7] MSC in bone marrow (BM) as a very rare
population (0.01% to 0.001%), and Wexlel et al[8]
reported a 1 in 3.4 × 104 frequency for these cells. We esti-
mated that about 1 in 3.1 × 104 bone marrow mononu-
clear cells are MSC (unpublished data). Their level is even
lower in cord blood9 and peripheral blood. Thus, it is
essential to culture and populate MSC in vitro before
putting them to therapeutic use. Scientific literature state
that telomere length shortens after each division cycle.
This leads to a gradual senescence. However, in vitro cul-
ture has proven that environmental conditions and differ-
ing treatment significantly increase or decrease culture life
span. It seems as though depending on conditions cells
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are exposed to, rate of decrease in telomere length varies,
leading to the observed differences. For example, Van
Zglinicki et al reported that cells incubated in 40% oxygen
soon stopped growing and, at the same time, had short-
ened telomeric DNA. They showed that telomeric DNA
can be lost without cell division, perhaps by single-strand
breaks in DNA[10].
With this in mind, we designed a study to evaluate the
effect of long term invitro culture on the proliferation, dif-
ferentiation, telomere length, phenotype, and morphol-
ogy of these cells.
Results
The results of MSC culture
Three days after plating BM mononuclear cells in culture
flasks, the mean number of fibroblast like cells were about
6800 (90 cell/cm2) of total heterogeneous cells. Gradu-
ally, the fibroblast like cells (MSC) increased and the het-
erogeneous cells decreased in the culture.
The predominant cell after 2 weeks of culture was fibrob-
last like (Fig. 1a) and dislodged readily on trypsinization
in 3 minutes.
Primary culture took between 11 and 25 days (mean: 15.6
day). The total count of harvested cells from primary cul-
ture was between 5.4 × 105 and 39.0 × 105 (mean: 17.0 ×
105 cell). The mean number of harvested MSC and the
mean time of confluency from the second culture on is
shown in table 1. As can be seen in table 1, the average
number of cells that proliferate during each passage and
the average confluency time in the various passages are
different. To analyze these differences we performed the
Repeated Measurement Analysis of Variance statistical
test, but we did not find any significant difference
between the different passages.
To evaluate whether donor age affects in vitro cell senes-
cence, we divided our donors into two groups. The first
group included 6 individuals under the age of 10, and the
remaining 5 who were between the ages of 23–63 made
up the second group.
Independent sample Test and Repeated Measurement
Analysis was performed to evaluate telomere length, PD
level, harvested cell dose and confluency time for each
passage. No significant difference was observed.
The goal of this study was keeping the MSC in the culture
by multiple passages up to 120 days. Nine of the 11 sam-
ples survived between 100 and 164 days and were pas-
saged between 8 to 10 times. Two samples survived up to
63 and 95 days, and were passaged 5 and 6 times respec-
tively (they didn't undergo the full procedure due to con-
tamination).
Immunophenotype of MSC
The mean percent of CD expression of the three antigens
in 5 different passages was compared using Repeated
Measurement Analysis of Variance test. Results demon-
strate no significant difference in their expression. These
cells stained positively for CD44 and CD13 but negative
or very low positive for CD34.
Differentiation of BM MSC
MSC were differentiated along adipogenic and osteogenic
lineages. Oil red O staining for adipocyte and Van Kossas
and Alkaline phosphatase staining for osteocyte were pos-
itive (Fig. 1b). Adipogenic differentiation of MSC after 2–
3 weeks incubation in adipocyte culture media demon-
strated scattered aggregates of oil red o positive staining
cells. But within the same time limit, the osteocyte culture
media exhibited a homogeneous and relatively abundant
number of Van Kossas positive cells.
The differentiation ability of MSC varied in the 5 different
passages. Every one of the samples cultured in osteogenic
and adipogenic mediums differentiated to osteocyte and
adipocytes by the 4th culture. In the 8th passage, 25% (2
of 8), and in the 10th passage, 20% (1 of 5) of the samples
lost their osteogenic differentiation potential. For adi-
a) Bone Marrow MSC in conventional culture (adherent,  elongated cells) Figure 1
a) Bone Marrow MSC in conventional culture (adherent, 
elongated cells); b) Oil red O staining showing fat accumula-
tion in adipocytes. c & d) Van Kossas and Alkaline Phos-
phatase staining showing osteocytes differentiation of MSC.BMC Cell Biology 2006, 7:14 http://www.biomedcentral.com/1471-2121/7/14
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pocytes, in the 6th passage 10% (1 of 10), in the 8th pas-
sage 50% (4 of 8), and in the 10th passage 60% (3 of 5)
of the samples lost their adipogenic differentiation poten-
tial. The percentage of samples with the ability to differen-
tiate into osteocyte and adipocyte in advancing CPD is
shown in table 2.
Long-term growth kinetics
To examine long-term growth kinetics of MSC culture, we
measured cumulative population doublings (PDs), with
respect to the passage number in multiple donors. The
average number of cumulative PD in 130 days was about
30 (range 26–32). MSC underwent an average of 7.7 PDs
prior to the first passage. The mean PD and growth kinet-
ics of different samples upon subsequent passages is
shown in table 1 and Figure 1d, respectively.
Morphological characteristics of BM MSC in long-term 
culture
After a long period of normal growth, MSC culture
showed abnormalities typical of the Hayflick model of
cellular aging in cultured human fibroblasts 12. The cells
varied in size and shape, the cytoplasm began to be gran-
ular with many cell inclusions, and debris was formed in
the medium. On average, granules were noted in the cyto-
plasm after 84 days (range: 62–122), while debris forma-
tion was observed in medium after about 72 days (range:
35–97) after primary culture. However, in later stages,
around day 120 in some cultures, the granular cell began
to be vacuolated, rounded and finally detached from the
base of the flasks.
Telomere length of MSC
The range of the mTRFL varied between 10.2 kbp to 7.8
kbp in different BM samples and in different passages.
mTRFL decreased from an average of 9.19 kbp in the first
passage to 8.75 kbp in the 9th passage (Fig. 2), giving a tel-
omere shortening of about 0.44 kbp within 120 days of
expansion (table 1).
Discussion
Since MSC can differentiate into multiple tissues in vitro
and in vivo, they attract a lot of attention in cell and gene
therapy. The low frequency of MSC in BM[7,8] necessi-
tates their in vitro expansion prior to clinical use. It is
known that when the cells become senescent, they are
unable to proliferate further. As a result, it is necessary to
evaluate the proliferative capacity of expanded MSC to
maintain long-term tissue regeneration before re-infu-
sion.
The key feature of senescence in dividing cells is a long
period of normal growth followed by cessation of growth.
So, throughout their life span, certain events must bring
about senescence. Our study has shown a number of
changes in physiological, functional, and molecular
parameters that occurred during long-term cultures. These
changes included:
- Typical Hayflick Phenomenon of cellular aging
- Gradual decreasing proliferation potential
- Telomere shortening
- Impairment of functions
The actual age of a culture is normally recorded in popu-
lation doublings (PDs). Colter et al[13] reported that the
single-cell-derived colonies of MSC can be expanded up to
as many as 50 PDs in about 10 weeks. But we found that
MSC can be expanded up to 30 PDs, similar to Kassem et
al11, in about 130 days (18 weeks).
The curve relationship between cumulative PD and dura-
tion of culture demonstrates a relatively linear decreasing
PD rate with the progression of time. Furthermore, an
appreciable decrease in the number of PD was seen in the
latter days (more than 130 days in culture), suggesting
that MSC proliferative potential decreases faster after 120
Table 1: The result of the mean and SD of BM-MSC culture.
passage number Mean number of harvested 
cell (× 104) ± SD
Mean time of counfluency 
(day) ± SD
Mean number of PD ± SD Mean number of telomere 
length (Kbp) ± SD
1th passage 170 ± 105.26 15 ± 4.23 7.7 ± .55 9.2 ± .60
2th passage 404 ± 190.72 10 ± 4.78 3.1 ± .67 -
31th passage 280 ± 148.52 12 ± 4.10 2.6 ± .68 9.0 ± .56
4th passage 283 ± 103.55 12 ± 1.75 2.6 ± .58 -
5th passage 258 ± 109.73 14 ± 4.76 2.5 ± .56 8.9 ± .58
6th passage 232 ± 122.26 16 ± 5.94 2.3 ± .61 -
7th passage 206 ± 152.95 14 ± 5.27 2.0 ± .81 8.8 ± .56
8th passage 175 ± 77.57 14 ± 4.71 1.9 ± .69 -
9th passage 210 ± 134.06 17 ± 4.65 2.1 ± .82 8.7 ± .75
10th passage 109 ± 61.68 15 ± 3.35 1.2 ± .73 -BMC Cell Biology 2006, 7:14 http://www.biomedcentral.com/1471-2121/7/14
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days in vitro expansion. To investigate the aging of MSC
morphologically, we studied the culture for the presence
of any abnormalities in cell morphology. Production of
debris in the medium and granules in the cytoplasm has
been used as markers for fibroblast aging in vitro[14]. In
the present study, granulated cytoplasm and debris was
observed and increased from the third month on.
We investigated another marker for cellular senescence,
normally the mean telomere length. In the absence of the
enzyme telomerase, telomeres gradually get shorter as cell
division proceeds, and shortening of telomere throughout
the life span is well-documented[15]. The consequence
maybe the inactivation of genes closest to the telomere
sequences, either directly or indirectly by a position effect,
perhaps involving the formation of heterochromatin.
However, maintenance of telomere length has been
observed in germ cells, some stem cells and malignant
cells due to activation of the telomerase enzyme[16].
Our present study shows that MSC senescence is associ-
ated with telomere shortening during in vitro expansion.
The rate of telomere shortening was 100 bp in every two
passage. Other studies[17,18] have shown that the tel-
omere length of MSC shortens in culture expansion. How-
ever the rate of telomere shortening in Kassem et al[11]
study was 100 bp/PD, which is very high in comparison
to our study. This difference maybe due to the long period
of their culture (> 500 days) in comparison to our study
(120 days). They showed that mTRFL decreased from an
average of 10.4 kb in early passage cells to 7.1 kbp in late
passage cells. Although loss of mTRFL in later passages is
high but the mean amount of shortening was divided by
the cumulative PD number. This could partly explain the
difference.
In addition to the telomere length shortening, we investi-
gated the osteogenic and adipogenic differentiation
capacity of MSC. MSC differentiation into other lineages
has been used as a marker for the multipotential nature of
these cells[19]. In our study, the differentiation potential
to adipocyte and osteocyte dropped in the late-passages,
similar to previous reports[20,21]. Our study also demon-
strated that, in the later passages, a greater number of sam-
ples lose their adipocyte differentiation potential in
comparison to osteocytes in the same condition. At the
level of one culture plate, the percentage of cells that dif-
ferentiated into adipocyte were lower than those differen-
tiating into osteocytes.
It is generally agreed that senescent cells are irreversibly
blocked in cell division, but they are still capable of many
other cell functions. According to the telomere theory of
cellular senescence, the shortening of chromosome ends
would itself trigger a cell cycle block.
Stenderup et al.[11] showed that donor age affects rate of
in vitro senescence in MSC. They define their old age
group as above 66 years of age, and compare this with a
group of donors ranging from 18–29 years. The difference
they observe is significant. In our study, no significance in
age difference was observed. This could be directly due to
the donor age we had (all below 63 and six below 10).
When there is talk of aging, transformation and tumori-
genesis inevitably lingers in the background. In some
cases, we observed changes from elongated adherence
cells to rounded non-adherent cells after 120 days. Today,
this phenomenon is noted as a mark of transformation
into cancerous cells. Interestingly, recent studies highlight
this issue in invitro culturing. Rubiro et al.[22] demon-
strated that adipocyte tissue derived hMSC under long
term culture conditions, upon entering old age, spontane-
ously transform into small, clustered aggregations dis-
Long term growth curves; each obtained from an individual  donor Figure 2
Long term growth curves; each obtained from an individual 
donor.
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Table 2: The percent of samples which differentiate to adipocyte 
and osteocyte in ongoing CPDs after 2–3 week culture period is 
shown here.
CPD No. Adipocytes Osteocytes
10 100 % 100 %
15 100 % 100 %
20 90 % 90 %
25 50 % 75 %
30 40 % 80 %BMC Cell Biology 2006, 7:14 http://www.biomedcentral.com/1471-2121/7/14
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playing molecular and chromosomal changes and
abnormalities at a rate of 50% or so. Serakinci et al.[23]
report a similar change in long term culture. They note
that transduced cells develop characteristics which corre-
late with the acquisition of tumorigenic phenotype (loss
of contact inhibition, cell cycle regulation alteration,
senescence, ...) in PDL above 70. They report that these
cells do not undergo such alterations in lower PDs. It is
notable that as cells age, transformations become more
common.
Conclusion
Our results suggest that MSC enter senescence and start to
lose their stem cell characteristics almost undetectably
from the moment in vitro culture begins. MSC should
therefore be considered for cell and gene therapy only at
the early stages of in vitro culture.
Methods
Sample collection and MSC cultures
Ten ml of BM was obtained from 11 (5 female, 6 male)
healthy hematopoietic stem cell transplant donors. None
of the donors had used any medication or growth factor at
the time of collection. Informed consent according to an
approved protocol by the internal medicine ethics com-
mittee was obtained. The mean age of BM donors was 25
years (range: 2.5 to 63).
The mononuclear cells (MNCs) were isolated from the
collected samples by the Ficoll density gradient method.
Then, they were washed in RPMI 1640 and resuspended at
1 × 106 cells/ml in culture medium [Dulbecco's modified
Eagle medium, low glucose (DMEM-LG), 10% (v/v) heat-
inactivated fetal bovine serum (FBS) and penicillin/strep-
tomycin (all from Gibco)]. Twenty-one ml of Cell suspen-
sion was plated in a 75 cm2 flask (Greiner bio-one) for
primary culture.
Flasks were incubated at 37°C in a humidified atmos-
phere of 5% CO2 and fed by complete medium replace-
ment every 4 days. When fibroblast-like cells at the base of
the flask reached more than 90% confluence, adherent
cells were detached using 0.25% trypsin EDTA and
replated (passaged) at a density of 1 × 104 cells/ml in two
75 cm2 flasks. On reaching confluence, all cultures were
passaged sequentially up to 120 days. For every even pas-
sage, some of the expanded MSC was separated for adi-
pocyte and osteocyte differentiation potential and
immunophenotype testing. For every odd passage, the
cells were examined for telomere length.
Immunophenotyping
Surface expression of CD44, CD13 and CD34 was deter-
mined on culture-expanded MSC. The monoclonal anti-
bodies used were anti-CD44 fluorescein isothiocyanate
(FITC), anti-CD13 phycoerythrin (PE), and anti-CD34
FITC (all from Dako). Relevant isotope control antibodies
were also used. Flow cytometry was performed on a FAC-
Scan (Becton Dickinson), and data were analyzed with
Cellquest software.
Differentiation of MSC
Adipogenic differentiation was assessed by incubating the
cells with DMEM-LG and 10% FBS supplemented with
0.5  µM hydrocortisone, 0.5 µM isoboutyl methylxan-
thine, 60 µM indomethacin (Sigma-Aldrich), and 10 µg/
ml insulin (R&D) for 2–3 weeks. Adipocyte is recognized
by the accumulation of lipid-containing vacuoles which
stain red with Oil red O.
Osteogenic differentiation was assessed by incubating the
cells with DMEM-LG and 10% FBS supplemented with
0.1 µM dexamethasone, 10 µM β-glycero-phosphate, and
50 µM ascorbate (all from Sigma-Aldrich) for 2–3 weeks.
To assess mineralization, cultures were stained with silver
nitrate (Von Kossa's staining).
Determination of population doubling level and 
morphological characteristics of long term culture
Long-term cell growth in vitro is a sensitive method to
detect subtle changes in the kinetics of proliferation of the
cell population. To determine the number of cumulative
population doublings, BM mononuclear cells were seeded
1 × 106 cell/ml (28 × 104 cell/cm2) in T-75 flasks. The
adherent MSC were counted after 3–4 days to quantify the
initial number. At confluence, the cells were trypsinized,
counted and reseeded at a density of 1 × 104/ml (2.8 ×
Southern-blot analysis of telomere lengths of expanded  MSCs derived from two BM samples during multiple passages  (CH = Control-DNA, High, CL = Control-DNA, Low, P =  Passage) Figure 3
Southern-blot analysis of telomere lengths of expanded 
MSCs derived from two BM samples during multiple passages 
(CH = Control-DNA, High, CL = Control-DNA, Low, P = 
Passage).BMC Cell Biology 2006, 7:14 http://www.biomedcentral.com/1471-2121/7/14
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103 cell/cm2). The numbers of PDs were calculated using
the formula logN/log2 11, where N is the cell number of
the confluent monolayer divided by the initial number of
cells seeded. This procedure was repeated in every passage.
To study the morphological characteristics, cell culture
flasks were observed every time at medium re-feeding
intervals (every 4 day), to detect any abnormalities in cell
morphology and medium. When any variation was
observed, the changes were recorded in the culture files.
Determination of telomere length
For telomere length assay, we used the "Telo TAGGG Tel-
omere Length Assay" kit (Roche Molecular Biochemical)
according to the manufacturer's recommendations.
Briefly, the test principle is as follows: The genomic DNA
was isolated and digested using restriction enzymes RsaI
and HinfI for 2 h at 37°C. The DNA fragments were sepa-
rated by gel electrophoresis for 2–4 h at 70 V on a 0.8%
agarose gel and transferred to a nylon membrane by
Southern blotting.
The blotted DNA fragments are hybridized to a digoxi-
genin (DIG)-labeled probe specific for telomeric repeats
and incubated with a DIG-specific antibody covalently
coupled to alkaline phosphate. Finally, the immobilized
telomere probe is visualized by virtue of alkaline phos-
phatase metabolizing CDP-Star, a highly sensitive chemi-
luminescence substrate. The average TRF length can be
determined by comparing the signals relative to a molec-
ular weight standard.
After exposure of the blot to an X-ray film, the mean TRF
length were scanned and calculated by the multianalizor
(Bio-rad) software.
Statistical analysis
All data are presented as mean ± SD. The data collected in
ten passages was compared by Repeated Measurement
analysis of variance test. P. values of less than P < 0.05
were considered significant.
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